Professional Summary

Professional Overview

Timothy McKeown is a seasoned executive with a proven track record of success in the biotechnology and healthcare industries. As the President and CEO of Mass Probiotics, Inc. and the Founder, CEO, and Director of Product Development at Biologic Technologies, Inc., he leverages his extensive expertise in product development, strategic leadership, and business operations to drive innovation and growth.

Experience Summary

Current Roles

President & CEO at Mass Probiotics, Inc. (2014-01-01 to Present)

Provides strategic vision and executive leadership to the company, guiding the development and commercialization of innovative probiotic products.

Oversees all aspects of the business, including product R&D, manufacturing, sales, and marketing, to ensure the delivery of high-quality, effective solutions to the market.

Spearheads the company's expansion into new markets and the development of novel probiotic formulations to address evolving consumer and industry needs.

Founder, CEO, Director of Product Development at Biologic Technologies, Inc. (2020-10-01 to Present)

Leads the strategic direction and day-to-day operations of the biotechnology company, driving the development and commercialization of cutting-edge biologic therapies.

Responsible for the design, testing, and regulatory approval of the company's innovative product pipeline, leveraging his expertise in product development and regulatory affairs.

Builds and manages a cross-functional team of scientists, engineers, and business professionals to execute the company's strategic objectives.

Career Progression

Managing Partner at The Targhee Group, LLC (2003-01-01 to Present)

Provides strategic consulting and advisory services to clients in the biotechnology, healthcare, and financial services industries.

Advises on various aspects of business strategy, product development, and market expansion, drawing on his extensive industry experience and expertise.

Senior Vice President at Jefferies & Company (2002-01-01 to 2003-01-01)

Played a key role in the firm's investment banking and advisory services, focusing on the biotechnology and healthcare sectors.

Contributed to the successful execution of numerous transactions, including mergers, acquisitions, and capital raises.

Vice President at Robertson Stephens (1998-01-01 to 2002-01-01)

Served as a member of the biotechnology and healthcare investment banking team, providing strategic advice and execution support to clients.

Participated in the development and implementation of innovative financing solutions to support the growth and expansion of biotechnology and healthcare companies.

Management Consultant at Marakon Associates (1996-01-01 to 1998-01-01)

Advised clients in the biotechnology, pharmaceutical, and medical device industries on strategic and operational issues.

Contributed to the development of growth strategies, operational improvements, and organizational transformations.

Financial Development Program (FDP) - Management Rotations at Digital Equipment Corporation (USA) (1987-01-01 to 1994-01-01)

Participated in a comprehensive finance and management training program, gaining broad exposure to various business functions and departments.

Developed a well-rounded understanding of corporate finance, strategy, and operations.

Finance at IBM (1986-01-01 to 1987-01-01)

Gained early experience in the finance function at a leading technology company.

Academic Background

Timothy McKeown holds a Bachelor of Science in Finance from the University of Pennsylvania's Wharton School, where he graduated with honors.

Areas of Expertise

Biotechnology and healthcare product development

Strategic business planning and execution

Regulatory affairs and compliance

Financial management and investment banking

Mergers, acquisitions, and capital raises

Strategic consulting and advisory services

Cross-functional team leadership and collaboration

Professional Impact

Instrumental in the successful development and commercialization of several innovative probiotic and biologic products, improving patient outcomes and enhancing industry standards.

Recognized as a thought leader in the biotechnology and healthcare industries, frequently invited to speak at industry conferences and events.

Actively engaged in industry associations and regulatory bodies, contributing to the advancement of policies and regulations that foster innovation and patient-centric care.